Literature DB >> 28102763

The best defense is a good (Protease) offense: How Pseudomonas aeruginosa evades mucosal immunity in the lung.

Lisa A Miller1.   

Abstract

Entities:  

Keywords:  IL-22; Pseudomonas; lung; mucosa

Mesh：

Substances：

Year:  2017        PMID： 28102763      PMCID： PMC5626340          DOI： 10.1080/21505594.2016.1278335

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  26 in total

Review 1.  Emerging and resistant infections.

Authors:  Cornelius J Clancy; Andre C Kalil; Vance G Fowler; Elodie Ghedin; Jay K Kolls; M Hong Nguyen
Journal:  Ann Am Thorac Soc       Date:  2014-08

Review 2.  Update in Critical Care 2015.

Authors:  Martin Dres; Jordi Mancebo; Gerard F Curley
Journal:  Am J Respir Crit Care Med       Date:  2016-07-01       Impact factor: 21.405

3.  Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.

Authors:  Antoine Guillon; Deborah Brea; Eric Morello; Aihua Tang; Youenn Jouan; Reuben Ramphal; Brice Korkmaz; Magdiel Perez-Cruz; Francois Trottein; Richard J O'Callaghan; Philippe Gosset; Mustapha Si-Tahar
Journal:  Virulence       Date:  2016-10-28       Impact factor: 5.882

Review 4.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

5.  Predominant pathogens in hospital infections.

Authors:  W R Jarvis; W J Martone
Journal:  J Antimicrob Chemother       Date:  1992-04       Impact factor: 5.790

6.  Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa.

Authors:  L S Engel; J M Hill; A R Caballero; L C Green; R J O'Callaghan
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

8.  Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response.

Authors:  Jean Baptiste Mear; Philippe Gosset; Eric Kipnis; Emmanuel Faure; Rodrigue Dessein; Samir Jawhara; Chantal Fradin; Karine Faure; Daniel Poulain; Boualem Sendid; Benoit Guery
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

9.  Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis.

Authors:  Marthe S Paats; Ingrid M Bergen; Marleen Bakker; Rogier A S Hoek; Karin J Nietzman-Lammering; Henk C Hoogsteden; Rudi W Hendriks; Menno M van der Eerden
Journal:  J Cyst Fibros       Date:  2013-06-14       Impact factor: 5.482

Review 10.  Pseudomonas aeruginosa ventilator-associated pneumonia management.

Authors:  Sergio Ramírez-Estrada; Bárbara Borgatta; Jordi Rello
Journal:  Infect Drug Resist       Date:  2016-01-20       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.